Shares of ValiRx plc (LON:VAL – Get Free Report) dropped 9.5% during trading on Thursday . The company traded as low as GBX 0.40 ($0.01) and last traded at GBX 0.43 ($0.01). Approximately 1,353,628 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 7,439,741 shares. The stock had previously closed at GBX 0.48 ($0.01).
ValiRx Stock Down 9.5 %
The business’s 50-day moving average is GBX 0.65 and its two-hundred day moving average is GBX 1.06. The firm has a market capitalization of £1.63 million, a price-to-earnings ratio of -0.29 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Recommended Stories
- Five stocks we like better than ValiRx
- How to Evaluate a Stock Before Buying
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The 3 Most Talked About Investments on WallStreetBets Right Now
- 3 Small Caps With Big Return Potential
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
